Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin in children and adolescents with high-risk hyperlipidaemia
NL-OMON37577Phase 3Active, not recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pitavastatin in hyperlipidemia (4 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Percent change in LDL-C from baseline to Week 12. Started Apr 2012; status: active, not recruiting.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NL-OMON37577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37577.